Solid Biosciences Inc. Quarterly Debt-to-equity in % from Q3 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Solid Biosciences Inc. quarterly Debt-to-equity history and growth rate from Q3 2018 to Q2 2024.
  • Solid Biosciences Inc. Debt-to-equity for the quarter ending June 30, 2024 was 22.9 %, a 8.91% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 22.9 -2.24 -8.91% Jun 30, 2024
Q1 2024 24.5 -1.49 -5.74% Mar 31, 2024
Q4 2023 26.8 +4.29 +19.1% Dec 31, 2023
Q3 2023 25 +5.86 +30.7% Sep 30, 2023
Q2 2023 25.1 +9.98 +65.9% Jun 30, 2023
Q1 2023 25.9 +14.3 +122% Mar 31, 2023
Q4 2022 22.5 +10.6 +88.7% Dec 31, 2022
Q3 2022 19.1 +4.36 +29.5% Sep 30, 2022
Q2 2022 15.2 -3.07 -16.8% Jun 30, 2022
Q1 2022 11.7 -12.2 -51.1% Mar 31, 2022
Q4 2021 11.9 -24.7 -67.5% Dec 31, 2021
Q3 2021 14.8 -23.6 -61.5% Sep 30, 2021
Q2 2021 18.2 -9.98 -35.4% Jun 30, 2021
Q1 2021 23.9 -2 -7.74% Mar 31, 2021
Q4 2020 36.6 +12.8 +53.8% Dec 31, 2020
Q3 2020 38.3 +19.3 +102% Sep 30, 2020
Q2 2020 28.2 +13.2 +87.4% Jun 30, 2020
Q1 2020 25.9 +15.2 +144% Mar 31, 2020
Q4 2019 23.8 +16.4 +219% Dec 31, 2019
Q3 2019 19 +9.05 +91% Sep 30, 2019
Q2 2019 15.1 Jun 30, 2019
Q1 2019 10.6 Mar 31, 2019
Q4 2018 7.46 Dec 31, 2018
Q3 2018 9.95 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.